Last updated: 2026-10-13 21:51:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
HeartSciences Inc. (HSCS) operates in the FINANCE SERVICES sector and is listed on NASDAQ. The stock is currently priced at $3.10, with a market capitalisation of $15.40M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.63 to $5.25. This page covers its latest market performance, valuation, price trends and company information.
$15.40M | |
$3.36 | |
$600.00 | |
$1.63 | |
$3.30 | |
89.65K | |
157.74K | |
-- | |
$5.25 | |
$1.63 | |
-- | |
-- |
HeartSciences Inc. (HSCS) is trading at $3.24 in after-hours trading as of 2026-10-13 21:32:00, down 1.82% ($0.06) from the regular-session close of $3.30.
After-hours trading shows how investors are pricing HSCS after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, HeartSciences Inc. (HSCS) moved from $4.30 to $3.10, representing a decline of 28.02% ($1.20).
The stock traded between $3.02 and $4.63 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 473.67 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 40.5%
HSCS is currently trading at $3.10, placing it 40.5% of the way from its 52-week low of $1.63 to its 52-week high of $5.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
| Industry | FINANCE SERVICES |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of HeartSciences Inc. (HSCS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.